Barclays’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-433
| Closed | – | – | 4825 |
|
|
2022
Q3 | $0 | Sell |
433
-6,000
| -93% | – | ﹤0.01% | 5025 |
|
|
2022
Q2 | $7K | Buy |
6,433
+4,000
| +164% | +$4.35K | ﹤0.01% | 4431 |
|
|
2022
Q1 | $12K | Hold |
2,433
| – | – | ﹤0.01% | 4463 |
|
|
2021
Q4 | $13K | Sell |
2,433
-691
| -22% | -$3.69K | ﹤0.01% | 3133 |
|
|
2021
Q3 | $34K | Buy |
3,124
+105
| +3% | +$1.14K | ﹤0.01% | 3483 |
|
|
2021
Q2 | $52K | Sell |
3,019
-3,262
| -52% | -$56.2K | ﹤0.01% | 3383 |
|
|
2021
Q1 | $166K | Buy |
6,281
+2,624
| +72% | +$69.3K | ﹤0.01% | 3203 |
|
|
2020
Q4 | $131K | Sell |
3,657
-2,099
| -36% | -$75.2K | ﹤0.01% | 2883 |
|
|
2020
Q3 | $203K | Buy |
5,756
+627
| +12% | +$22.1K | ﹤0.01% | 2733 |
|
|
2020
Q2 | $217K | Buy |
5,129
+4,816
| +1,539% | +$204K | ﹤0.01% | 2768 |
|
|
2020
Q1 | $25K | Sell |
313
-630
| -67% | -$50.3K | ﹤0.01% | 3332 |
|
|
2019
Q4 | $87K | Buy |
943
+477
| +102% | +$44K | ﹤0.01% | 3472 |
|
|
2019
Q3 | $35K | Sell |
466
-142
| -23% | -$10.7K | ﹤0.01% | 3769 |
|
|
2019
Q2 | $61K | Buy |
+608
| New | +$61K | ﹤0.01% | 3784 |
|